Overestimation of asthma control and misperception of short-acting β2-agonists (SABA) use among physicians in Poland

被引:1
|
作者
Gawlik, Radoslaw [1 ]
Bochenek, GraZyna [2 ]
Brzostek, Dorota [3 ]
Barg, Wojciech [4 ]
Brozek, Grzegorz [5 ]
Dabrowiecki, Piotr [6 ]
Dabrowski, Andrzej [7 ]
Dobek, Rafal [8 ]
Kucharczyk, Aleksandra [9 ]
Kupczyk, Maciej [10 ]
Kuprys-Lipinska, Izabela [10 ]
Mastalerz-Migas, Agnieszka [11 ]
Kowalski, Marek L. [12 ]
机构
[1] Med Univ Silesia, Div Dent Zabrze, Sch Med, Dept Internal Med Allergol & Clin Immunol, Katowice, Poland
[2] Jagiellonian Univ, Sch Med, Fac Med, Dept Internal Med, Krakow, Poland
[3] AstraZeneca Sp Zoo, Warsaw, Poland
[4] Med Univ Wroclaw, Dept Internal Med & Allergy, Wroclaw, Poland
[5] Med Univ Silesia, Sch Med Katowice, Dept Epidemiol, Katowice, Poland
[6] Mil Inst Med, Dept Infect Dis & Allergol, Warsaw, Poland
[7] Warsaw Med Univ, Chair & Dept Internal Med Pneumonol & Allergol, Warsaw, Poland
[8] Inst TB & Lung Dis, Dept Lung Dis 2, Warsaw, Poland
[9] Mil Inst Med, Dept Internal Med Pneumonol Allergol & Clin Immun, Warsaw, Poland
[10] Med Univ Lodz, Dept Internal Med Asthma & Allergy, Lodz, Poland
[11] Wroclaw Med Univ, Dept Family Med, Wroclaw, Poland
[12] Med Univ Lodz, Hlth Ageing Res Ctr, Chair Clin Immunol & Microbiol, Dept Immunol Rheumatol & Allergy, Lodz, Poland
关键词
D O I
10.1183/13993003.congress-2020.958
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
958
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Overestimation of asthma control and misperception of the place of short-acting β2-agonists in asthma management: a prospective, real-world study among physicians in Poland
    Gawlik, Radoslaw
    Bochenek, Grazyna
    Brzostek, Dorota
    Stasiulewicz, Adam
    Barg, Wojciech
    Brozek, Grzegorz
    Dabrowiecki, Piotr
    Dabrowski, Andrzej
    Dobek, Rafal
    Kucharczyk, Aleksandra
    Kupczyk, Maciej
    Kuprys-Lipinska, Izabela
    Mastalerz-Migas, Agnieszka
    Kowalski, Marek L.
    JOURNAL OF ASTHMA, 2025,
  • [2] Short-acting β2-agonists (SABA) overuse in asthma and patients' perceptions for this behavior
    Visser, Claire D.
    Faay, Maaike R. A.
    Ozdemir, Ayse
    Guchelaar, Henk-Jan
    Teichert, Martina
    RESPIRATORY MEDICINE, 2024, 231
  • [3] Detection of reasons for excessive use of short-acting β2-agonists (SABA) therapy in asthma: a descriptive study
    Visser, Claire D.
    Ozdemir, Ayse
    Faay, Maaike R. A.
    Guchelaar, Henk Jan
    Teichert, Martina
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (03) : 798 - 798
  • [5] Paradoxical asthma hazard of short-acting β2-agonists
    Seed, M. J.
    Agius, R. M.
    ALLERGY, 2008, 63 (02) : 241 - 241
  • [6] Short-acting β2-agonists
    Lee, T
    Dennis, S
    LANCET, 2000, 356 (9233): : 940 - 941
  • [7] Short-acting β2-agonists (SABA) bronchodilator sales and outdoor mould in central France
    Caillaud, D. M.
    Martin, S.
    Segala, C.
    Dupuy, N.
    Thibaudon, M.
    Muti, D.
    CLINICAL AND TRANSLATIONAL ALLERGY, 2019, 9 (01)
  • [8] Identifying the drivers of patients' reliance on short-acting β2-agonists in asthma
    Blakeston, Sarah
    Harper, Gavin
    Zabala Mancebo, Julen
    JOURNAL OF ASTHMA, 2021, 58 (08) : 1094 - 1101
  • [9] Regular use of corticosteroids and low use of short-acting β2-agonists can reduce asthma hospitalization
    Senthilselvan, A
    Lawson, JA
    Rennie, DC
    Dosman, JA
    CHEST, 2005, 127 (04) : 1242 - 1251
  • [10] Safety of Short-acting β2-agonists (SABA) in the management of hospitalized COPD patients with cardiovascular comorbidities
    Kassirer, Michael
    Sagie, Nitzan
    Gordon, Michal
    Cohen, Bracha
    Bar Haim, Evyatar
    Raviv, Yael
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64